Clinical Trial: Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07851012) titled 'Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients' on Sept. 15.

Brief Summary: The aim of this study is to evaluate and compare the cardiotoxic effects associated with anthracycline-based induction chemotherapy and those receiving a Venetoclax or HMA regimens after four cycles of chemotherpy in patients with newly diagnosed acute myeloid leukemia.

Study Start Date: Oct. 14

Study Type: OBSERVATIONAL

Condition: Newly Diagnosed Acute Myeloid Leukemia (AML)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Mohamed Fawzy Hussein Mohamed, Assiut University...